题名 | MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy |
作者 | |
发表日期 | 2024 |
发表期刊 | JOURNAL OF HEPATOCELLULAR CARCINOMA 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | hepatocellular carcinoma hepatectomy MRI radiomics |
其他关键词 | CANCER ; ALPHA |
摘要 | Background: A limited number of studies have examined the use of radiomics to predict 3-year overall survival (OS) after hepatectomy in patients with hepatocellular carcinoma (HCC). This study develops 3-year OS prediction models for HCC patients after liver resection using MRI radiomics and clinicopathological factors. Materials and Methods: A retrospective analysis of 141 patients who underwent surgical resection of HCC was performed. Patients were randomized into two set: the training set (n=98) and the validation set (n=43) including the survival groups (n=111) and non-survival groups (n=30) based on 3-year survival after hepatectomy. Furthermore, x 2 or Fisher's exact test, univariate and multivariate logistic regression analyses were conducted to determine independent clinicopathological risk factors associated with 3-year OS. 1688 quantitative imaging features were extracted from preoperative T2-weighted imaging (T2WI) and contrast-enhanced magnetic resonance imaging (CE-MRI) of arterial phase (AP), portal venous phases (PVP)and delay period (DP). The features were selected using the variance threshold method, the select K best method and the least absolute shrinkage and selection operator (LASSO) algorithm. By using Bernoulli Naive Bayes (BernoulliNB) and Multinomial Naive Bayes (MultinomialNB) classifiers, we constructed models based on the independent clinicopathological factors and Rad-scores. To determine the best model, receiver operating characteristics (ROC) and Delong's test were used. Moreover, calibration curves were used to determine the calibration ability of the model, while decision curve analysis (DCA) was implemented to evaluate its clinical benefit. Results: The fusion model showed excellent prediction precision with AUC of 0.910 and 0.846 in training and validation set and revealed significant diagnostic accuracy and value in the calibration curve and DCA analysis. Conclusion: Nomograms based on MRI radiomics and clinicopathological factors have significant predictive value for 3-year OS after hepatectomy and can be used for risk classification. |
资助项目 | Key Research & Development Plan of Zhejiang Province [2024C03171]; Projects of Lishui Key Research and Development Plan in Zhejiang Province [2022ZDYF08] |
出版者 | DOVE MEDICAL PRESS LTD |
ISSN | 2253-5969 |
EISSN | 2253-5969 |
卷号 | 11页码:1445-1457 |
DOI | 10.2147/JHC.S464916 |
页数 | 13 |
WOS类目 | Oncology |
WOS研究方向 | Oncology |
WOS记录号 | WOS:001271926500001 |
收录类别 | SCIE ; SCOPUS ; PUBMED |
URL | 查看原文 |
PubMed ID | 3905081 |
SCOPUSEID | 2-s2.0-85199500974 |
通讯作者地址 | [Tu, Chaoyong]Wenzhou Med Univ, Affiliated Hosp 5, Dept Hepatopancreatobiliary Surg, 289 Kuocang Rd, Lishui 323000, Zhejiang, Peoples R China. |
Scopus学科分类 | Oncology;Hepatology |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/216737 |
专题 | 附属第一医院 第一临床医学院(信息与工程学院)、附属第一医院 其他_附属第六医院(丽水市人民医院) 其他_附属第五医院(丽水市中心医院) |
通讯作者 | Tu, Chaoyong |
作者单位 | 1.Shaoxing Univ, Sch Med, Shaoxing 312000, Zhejiang, Peoples R China; 2.Lishui Univ, Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatopancreatobiliary Surg,People Hosp Lishu, Lishui 323000, Zhejiang, Peoples R China; 3.Wenzhou Med Univ, Affiliated Hosp 5, Dept Radiol, Lishui 323000, Zhejiang, Peoples R China; 4.Wenzhou Med Univ, Affiliated Hosp 5, Dept Hepatopancreatobiliary Surg, 289 Kuocang Rd, Lishui 323000, Zhejiang, Peoples R China; 5.Wenzhou Med Univ, Lishui Peoples Hosp, Affiliated Hosp 6, Key Lab Joint Diag & Treatment Chron Liver Dis & L, Lishui 323000, Zhejiang, Peoples R China; 6.Wenzhou Med Univ, Acad Clin Med 1, Wenzhou 325000, Zhejiang, Peoples R China; 7.Nanchang Univ, Clin Med Coll 1, Nanchang 330000, Jiangxi, Peoples R China |
第一作者单位 | 附属第一医院 |
通讯作者单位 | 附属第五医院(丽水市中心医院) |
推荐引用方式 GB/T 7714 | Kuang, Fangyuan,Gao, Yang,Zhou, Qingyun,et al. MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy[J]. JOURNAL OF HEPATOCELLULAR CARCINOMA,2024,11:1445-1457. |
APA | Kuang, Fangyuan., Gao, Yang., Zhou, Qingyun., Lu, Chenying., Lin, Qiaomei., ... & Shao, Chuxiao. (2024). MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy. JOURNAL OF HEPATOCELLULAR CARCINOMA, 11, 1445-1457. |
MLA | Kuang, Fangyuan,et al."MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy".JOURNAL OF HEPATOCELLULAR CARCINOMA 11(2024):1445-1457. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论